To evaluate preoperative anti-Müllerian hormone (AMH) levels in women with endometrioma or other benign ovarian cysts and differences of AMH changes according to various characteristics. Methods: Ninety-seven patients aged 20 to 39 years who underwent surgery for benign ovarian cyst were enrolled retrospectively. Of these, 65 patients were diagnosed as endometriomas, and 32 had other benign cysts. Serum AMH, mean, maximum, and total diameter of ovarian cysts were measured. The AMH levels were compared according to pathology (endometrioma vs. other benign cyst), size of ovarian cyst, age-matched AMH quartile percentile and characteristics of endometrioma. Results: Preoperative serum AMH level was significantly lower in endometrioma group than other benign cyst group (4.12 ± 2.42 ng/mL vs. 6.02 ± 2.29 ng/mL, P < 0.001). Serum AMH level was significantly lower in endometrioma group, especially in patients aged 30 to 39 years. Dividing to age-matched AMH quartile percentile, there were significantly fewer patients with AMH level ≥ 75 percentile in endometrioma group (24.6% vs. 50.0%, P = 0.035). Among 4 subgroups of endometrioma, patients with AMH level ≥ 75 percentile were significantly decreased in multiple bilateral endometrioma group. Mean and total diameter of cysts were negatively correlated with preoperative serum AMH level in other benign cyst group. Conclusion: We suggest that preoperative AMH level measurement might be considered in women with endometrioma, especially in 30 to 39 years old, multiple bilateral type, or big-sized other benign ovarian cyst to assess the diminished ovarian reserve. (J Menopausal Med 2015;21:142-148)
Introduction
Ovarian masses are uncertain of their etiology, and making a discrimination between benign masses and malignant masses is difficult. Several studies demonstrate the advantage of using cancer antigen 125 (CA-125) and risk of malignancy index (RMI). 1, 2 Benign ovarian cysts such as endometrioma, teratoma, serous or mucinous cystadenoma are frequently seen during reproductive age. Endometriosis is defined as the presence of endometrial tissue (gland and stroma) outside the uterus. It is estimated to occur in 10% of reproductive aged women and is associated with pelvic pain and infertility. The overall prevalence of endometriosis is greater in infertile women than in fertile women. 3 The etiology of endometriosis is not exactly known, however, polymorphism studies on estrogen receptor (ER) associated with the risk of endometriosis in different countries showed that the risk of endometriosis varies and it is associated
Müllerian hormone (AMH) is a dimeric glycoprotein within the transforming growth factor-beta superfamily, and is produced by the granulosa cells of primary to small antral follicles to prevent depletion of the primordial follicle pool.
AMH levels are independent of the menstrual cycle and are not affected by the use of gonadotropin-releasing hormone (GnRH) agonists or oral contraceptives. Hence, serum AMH measurement has been widely used in clinical practice for assessment of ovarian reserve and is currently measured frequently during the initial work-up for infertility.
12~14
Endometriosis is related to subfertility and many studies have shown corresponding results. Shebl et al. 15 demonstrated the association between low serum AMH levels and severity of women with endometriosis. In addition, Campos et al. 16 showed that patients with mi- groups divided by bilaterality and multiplicity and mean age.
However, according to the AMH percentile, patients with AMH level ≥ 75 percentile were significantly decreased in multiple bilateral endometrioma group (Table 2) .
By Pearson correlation coefficient, mean and total diameter of cysts were negatively correlated with preoperative serum AMH level in other benign cyst group (Table 3) .
Discussion
The present study was designed to compare the preoperative serum AMH levels between endometriomas and benign ovarian cysts. Our results showed that preoperative AMH level was significantly lower in endometrioma group than other benign ovarian cyst group in similar sized diameter. Additionally, this difference was statistically significant, especially in 30 to 39 years old. Increasing exponential follicle loss after the age of 30 years might aggravate the impact of endometrioma on diminished ovarian reserve. 24, 25 The levels of AMH reflect the number of preantral follicles; that comprise the oocyte pool.
Moreover serum levels of AMH are highly correlated with the antral follicle count assessed by ultrasonography and also with AMH concentrations measured in the follicular fluid. 26 Recently, AMH has been used in initial fertility work up and follow up studies on ovarian damage due to chemotherapy, ovarian surgery of diseases like endometriosis. In this study, we investigated the ovarian reserve impairment according to AMH percentile by age-specific serum AMH levels in Korean women and various characteristics.
The patients with AMH level ≥ 75 percentile were significantly decreased in endometrioma group, especially in multiple bilateral group. Ovarian follicles are firmly adjacent 
